We are live on
!
Find out more
WSL
Western Standard LLC Portfolio holdings
AUM
$190M
1-Year Est. Return
40.88%
This Fund
S&P 500
This Quarter
Est. Return
+8.85%
1 Year Est. Return
+40.88%
3 Year Est. Return
+68.87%
5 Year Est. Return
+221.93%
10 Year Est. Return
–
AUM
$150M
AUM Growth
+$39.5M
(+36%)
Cap. Flow
+$28M
Cap. Flow
% of AUM
18.66%
Top 10 Holdings %
Top 10 Hldgs %
80.23%
Holding
39
New
11
Increased
8
Reduced
9
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atmus Filtration Technologies
ATMU
|
+$4.16M |
| 2 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$3.52M |
| 3 |
EQC
Equity Commonwealth
EQC
|
+$2.77M |
| 4 |
Fidelity National Information Services
FIS
|
+$2.74M |
| 5 |
Abeona Therapeutics
ABEO
|
+$2.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dole
DOLE
|
+$8.99M |
| 2 |
Douglas Dynamics
PLOW
|
+$5.31M |
| 3 |
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
|
+$4.38M |
| 4 |
iRhythm Holdings
IRTC
|
+$3.46M |
| 5 |
HealthStream
HSTM
|
+$3.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.91% |
| 2 | Energy | 8.95% |
| 3 | Financials | 7.9% |
| 4 | Materials | 5.55% |
| 5 | Consumer Discretionary | 4.83% |
Similar funds
RCAP
HCM
CFA
CCA
G
BC
SCM
BCPWM
Western Standard LLC's Q4 2023 Portfolio in Review
As of Q4 2023, Western Standard LLC held 39 positions worth $150M, up 36% from $111M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Western Standard LLC deployed $28M of net new capital in Q4 2023, opening 11 new positions and adding to 8 existing holdings. Its largest new stake was Atmus Filtration Technologies: 194,209 shares worth $4.56M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 42% a quarter earlier, followed by Energy and Financials.
On the sell side, the largest reduction was Douglas Dynamics, an estimated $5.31M trimmed.
- Western Standard LLC's largest Q4 2023 buy was Atmus Filtration Technologies: 194,209 shares worth $4.56M.
- Western Standard LLC added most to Merrimack Pharmaceuticals, Inc. in Q4 2023, an estimated $3.52M increase.
- Western Standard LLC's biggest Q4 2023 reduction was Douglas Dynamics, cutting an estimated $5.31M.
- Western Standard LLC fully exited Dole in Q4 2023, selling an estimated $8.99M.
- Western Standard LLC's ten largest holdings make up 80% of its $150M portfolio in Q4 2023.
- Western Standard LLC opened 11 new positions and closed 8 in Q4 2023.
- Western Standard LLC's portfolio value rose 36% quarter-over-quarter to $150M.
Based on Western Standard LLC's 13F filing for Q4 2023, filed 14 Feb 2024.